ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 109 filers reported holding ANI PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,393,440 | +7.9% | 24,000 | 0.0% | 0.50% | +13.7% |
| Q2 2023 | $1,291,920 | +35.5% | 24,000 | 0.0% | 0.44% | +33.3% |
| Q1 2023 | $953,280 | -1.3% | 24,000 | 0.0% | 0.33% | -14.6% |
| Q4 2022 | $965,520 | +35.6% | 24,000 | 0.0% | 0.39% | +39.8% |
| Q3 2022 | $712,000 | 0.0% | 24,000 | 0.0% | 0.28% | 0.0% |
| Q2 2022 | $712,000 | +5.5% | 24,000 | 0.0% | 0.28% | +18.7% |
| Q1 2022 | $675,000 | -22.9% | 24,000 | +26.3% | 0.24% | -16.4% |
| Q4 2021 | $876,000 | +40.4% | 19,000 | 0.0% | 0.28% | +38.4% |
| Q3 2021 | $624,000 | -6.2% | 19,000 | 0.0% | 0.20% | -8.1% |
| Q2 2021 | $665,000 | -3.2% | 19,000 | 0.0% | 0.22% | -9.8% |
| Q1 2021 | $687,000 | +57.6% | 19,000 | +26.7% | 0.24% | +28.9% |
| Q4 2020 | $436,000 | +54.6% | 15,000 | +50.0% | 0.19% | +36.7% |
| Q3 2020 | $282,000 | – | 10,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |